Secretory and synaptic proteins in brain and cerebrospinal fluid in normal and Alzheimer’s disease animal models
Year: 2022
Type: dissertation
Abstract: [eng] The central nervous system represents a huge network architecture where intercellular communication governs and coordinates the proper function of the brain. Regulated secretion of neuropeptides and growth factors from dense-core vesicles (DCV) exert key roles in neural circuit development, function, and plasticity. However, these organelles have received significantly less attention than synaptic vesicles. Here, we investigated different aspects of DCV in the healthy and pathological brain by analyzing their molecular components. First, we studied the developmental acquisition of peptidergic regulated secretion in cortical neurons in situ and in vitro. We found that the competence for regulated secretion is determined sequentially for different DCV subsets. Importantly, the association between acquisition of regulated competence and levels and location of synaptotagmin-IV pointed out this vesicular component as a key mechanism in the developmental maturation of DCV secretion. Second, due to the significance of astrocytes in the neural circuitry physiology, we developed new adeno-associated vectors to express neuropeptides tagged with fluorescent proteins specifically in neurons, but also in astrocytes to evaluate glial peptidergic secretion into neuronal networks. Neuronal stimulation triggered a robust astrocyte DCV secretion in a calcium-dependent manner, presumably by NMDA glutamate receptors, although in a lesser extent than classical neuronal secretion. Last, alterations in synaptic function underlie early pathogenic events in Alzheimer’s disease (AD) which precedes symptoms onset but initiate a remarkably impairment of cognitive function. In line with recent research directed toward the identification of early biomarkers of synaptic degeneration, we studied age- and sex- dependent protein changes in the brain and cerebrospinal fluid (CSF) of TgF344-AD rats, evidencing alterations in DCV and other synaptic components even prior to Aβ deposition, markedly in males. The CSF proteome revealed that this transgenic model undergoes alterations in biological pathways involved in glia-neuron communication, neuronal assembly, memory or neuroinflammation. Hence, we consider TgF344-AD rats as a suitable model for the search of early fluid biomarkers that sustain the development of new therapeutic strategies for pre-clinical AD trials. Altogether, this dissertation shows new evidence of neuronal and glial communication in the physiology and neuropathology of the cerebral cortex.
Author: Sánchez Domínguez, Irene
Institution: Universitat de Barcelona
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7071316779
